Home
/
Nuvation Bio Inc.
/
Financials
/
Quarterly
Nuvation Bio Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Nuvation Bio Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.12M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$4.83M
Aug 7, 2025
Q3
2025
Sep 30, 2024
$727.0K
Nov 3, 2025
Q2
2025
Jun 30, 2024
$1.44M
Aug 7, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.12M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$4.83M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$3.08M
May 7, 2025
Q3
2025
Sep 30, 2024
$727.0K
Nov 3, 2025
Q2
2025
Jun 30, 2024
$1.44M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$0
May 7, 2025
Q3
2024
Sep 30, 2023
$0
Nov 6, 2024
Q2
2024
Jun 30, 2023
$0
Aug 5, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($55.79M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($59.01M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($59.01M)
Nov 3, 2025
Q1
2025
Mar 31, 2025
($53.24M)
May 7, 2025
Q2
2025
Mar 31, 2025
($53.24M)
Aug 7, 2025
Q3
2025
Mar 31, 2025
($53.24M)
Nov 3, 2025
Q3
2025
Sep 30, 2024
($41.21M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($462.49M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($462.49M)
Nov 3, 2025
Q3
2025
Mar 31, 2024
($14.79M)
Nov 3, 2025
Q2
2025
Mar 31, 2024
($14.79M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($14.79M)
May 7, 2025
Q3
2024
Sep 30, 2023
($19.65M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($20.64M)
Aug 5, 2024
Q3
2024
Jun 30, 2023
($20.64M)
Nov 6, 2024
Q2
2024
Mar 31, 2023
($21.73M)
Aug 5, 2024
Q3
2024
Mar 31, 2023
($21.73M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($21.73M)
May 14, 2024
Q3
2023
Sep 30, 2022
($27.20M)
Nov 2, 2023
Q3
2023
Jun 30, 2022
($34.86M)
Nov 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($56.43M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($63.59M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($59.00M)
May 7, 2025
Q3
2025
Sep 30, 2024
($48.10M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($470.39M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($20.20M)
May 7, 2025
Q3
2024
Sep 30, 2023
($26.34M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($26.13M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($26.52M)
May 14, 2024
Q3
2023
Sep 30, 2022
($29.34M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($37.87M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($28.19M)
May 4, 2023
Q3
2022
Sep 30, 2021
($22.79M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($20.43M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($20.48M)
May 9, 2022
Q3
2021
Sep 30, 2020
($11.55M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($9.02M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($9.22M)
May 17, 2021